Skip to main content

CE Credits & Learning Objectives

Learning Objectives

This course will provide the latest information on important development in clinical vaccinology and the use of vaccines.

Overall Course Objectives

At the conclusion of this activity, participants will be able to:

  • Explain how vaccines work in providing individual and community protection
  • Summarize current Advisory Committee on Immunization Practices (ACIP) immunization recommendations across the lifespan
  • Describe indications, contraindications, efficacy, and safety profiles for ACIP-recommended vaccines for routine vaccination and special situations
  • Describe the components of the US immunization system, including vaccine development, vaccine delivery, and outcome and safety monitoring
  • Discuss innovative and practical strategies to improve communication with patients, parents, and caregivers about the benefits and risks of vaccination and address vaccine hesitancy

Continuing Education Credits

Continuing Medical Education (CME)

Accreditation Statement
The National Foundation for Infectious Diseases (NFID) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation
NFID designates this enduring activity for a maximum of 13.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education (CNE)

Accreditation Statement
This nursing continuing professional development activity was approved by the Ohio Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. (OBN-001-91)

Credit Designation
This educational activity has been approved for a maximum of 13.50 contact hours.

Criteria for Successful Completion
To receive credit for this activity, participants must attend the course sessions and complete the online evaluation.

Expiration Date for enduring materials: January 31, 2022


2021 CVC Disclosures